• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成熟树突状细胞迁移需要HMGB1的分泌。

The secretion of HMGB1 is required for the migration of maturing dendritic cells.

作者信息

Dumitriu Ingrid E, Bianchi Marco E, Bacci Monica, Manfredi Angelo A, Rovere-Querini Patrizia

机构信息

Clinical Immunology Unit, H. San Raffaele Scientific Institute and Università Vita-Salute San Raffaele, via Olgettina 58, Milano 20132, Italy.

出版信息

J Leukoc Biol. 2007 Jan;81(1):84-91. doi: 10.1189/jlb.0306171. Epub 2006 Oct 11.

DOI:10.1189/jlb.0306171
PMID:17035340
Abstract

Chemokines regulate the migration and the maturation of dendritic cells (DC) licensed by microbial constituents. We have recently found that the function of DC, including their ability to activate naïve, allogeneic CD4+ T cells, requires the autocrine/paracrine release of the nuclear protein high mobility group box 1 (HMGB1). We show here that human myeloid DC, which rapidly secrete upon maturation induction their own HMGB1, remodel their actin-based cytoskeleton, up-regulate the CCR7 and the CXCR4 chemokine receptors, and acquire the ability to migrate in response to chemokine receptor ligands. The events are apparently causally related: DC challenged with LPS in the presence of HMGB1-specific antibodies fail to up-regulate the expression of the CCR7 and CXCR4 receptors and to rearrange actin-rich structures. Moreover, DC matured in the presence of anti-HMGB1 antibodies fail to migrate in response to the CCR7 ligand CCL19 and to the CXCR4 ligand CXCL12. The blockade of receptor for advanced glycation end products (RAGE), the best-characterized membrane receptor for HMGB1, impinges as well on the up-regulation of chemokine receptors and on responsiveness to CCL19 and CXCL12. Our data suggest that the autocrine/paracrine release of HMGB1 and the integrity of the HMGB1/RAGE pathway are required for the migratory function of DC.

摘要

趋化因子调节由微生物成分许可的树突状细胞(DC)的迁移和成熟。我们最近发现,DC的功能,包括其激活幼稚、同种异体CD4 + T细胞的能力,需要核蛋白高迁移率族蛋白B1(HMGB1)的自分泌/旁分泌释放。我们在此表明,人髓样DC在成熟诱导后迅速分泌自身的HMGB1,重塑其基于肌动蛋白的细胞骨架,上调CCR7和CXCR4趋化因子受体,并获得响应趋化因子受体配体而迁移的能力。这些事件显然存在因果关系:在存在HMGB1特异性抗体的情况下用LPS刺激的DC无法上调CCR7和CXCR4受体的表达,也无法重排富含肌动蛋白的结构。此外,在抗HMGB1抗体存在下成熟的DC无法响应CCR7配体CCL19和CXCR4配体CXCL12而迁移。晚期糖基化终产物受体(RAGE)是HMGB1最具特征的膜受体,其阻断也会影响趋化因子受体的上调以及对CCL19和CXCL12的反应性。我们的数据表明,HMGB1的自分泌/旁分泌释放以及HMGB1/RAGE途径的完整性是DC迁移功能所必需的。

相似文献

1
The secretion of HMGB1 is required for the migration of maturing dendritic cells.成熟树突状细胞迁移需要HMGB1的分泌。
J Leukoc Biol. 2007 Jan;81(1):84-91. doi: 10.1189/jlb.0306171. Epub 2006 Oct 11.
2
Mature monocyte-derived dendritic cells respond more strongly to CCL19 than to CXCL12: consequences for directional migration.成熟的单核细胞衍生树突状细胞对CCL19的反应比对CXCL12的反应更强烈:对定向迁移的影响。
Immunology. 2006 Feb;117(2):238-47. doi: 10.1111/j.1365-2567.2005.02292.x.
3
In situ leukemic plasmacytoid dendritic cells pattern of chemokine receptors expression and in vitro migratory response.原位白血病浆细胞样树突状细胞趋化因子受体表达模式及体外迁移反应
Leukemia. 2004 Sep;18(9):1491-8. doi: 10.1038/sj.leu.2403452.
4
EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation.EBI1/CCR7是树突状细胞趋化因子受体的一个新成员,在成熟时上调。
J Immunol. 1998 Sep 15;161(6):3096-102.
5
Neuroblastoma impairs chemokine-mediated dendritic cell migration in vitro.神经母细胞瘤在体外损害趋化因子介导的树突状细胞迁移。
J Pediatr Surg. 2006 Jan;41(1):260-5. doi: 10.1016/j.jpedsurg.2005.10.073.
6
Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin.人淋巴结与慢性炎症皮肤中DC-Lamp+成熟树突状细胞CCL19的差异表达。
J Pathol. 2003 Jan;199(1):98-106. doi: 10.1002/path.1255.
7
Synthetic chemokines directly labeled with a fluorescent dye as tools for studying chemokine and chemokine receptor interactions.直接用荧光染料标记的合成趋化因子作为研究趋化因子和趋化因子受体相互作用的工具。
Eur Cytokine Netw. 2006 Mar;17(1):49-59.
8
Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells.巨噬细胞和树突状细胞的基质细胞衍生因子-1/CXCL12依赖性迁移对高迁移率族蛋白B1的需求。
J Leukoc Biol. 2009 Sep;86(3):609-15. doi: 10.1189/jlb.0908576. Epub 2009 May 4.
9
The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells.CC趋化因子受体7配体6Ckine和巨噬细胞炎性蛋白-3β是体外和体内来源树突状细胞的有效趋化剂。
J Immunol. 1999 Apr 1;162(7):3859-64.
10
Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells.人浆细胞样树突状细胞成熟对高迁移率族蛋白B1(HMGB1)和晚期糖基化终末产物受体(RAGE)的需求
Eur J Immunol. 2005 Jul;35(7):2184-90. doi: 10.1002/eji.200526066.

引用本文的文献

1
Dendritic cell targeting in lymph nodes with modular adapters boosts HAdV5 and HC-HAdV5 tumor vaccination by co-secretion of IL-2v and IL-21.使用模块化衔接子靶向淋巴结中的树突状细胞,通过共分泌IL-2v和IL-21增强腺病毒5型和HC-腺病毒5型肿瘤疫苗接种效果。
Mol Ther Oncol. 2025 Apr 14;33(2):200984. doi: 10.1016/j.omton.2025.200984. eCollection 2025 Jun 18.
2
Regulated cell death and DAMPs as biomarkers and therapeutic targets in normothermic perfusion of transplant organs. Part 1: their emergence from injuries to the donor organ.调节性细胞死亡和损伤相关分子模式作为移植器官常温灌注中的生物标志物和治疗靶点。第1部分:它们从供体器官损伤中出现的情况。
Front Transplant. 2025 Apr 24;4:1571516. doi: 10.3389/frtra.2025.1571516. eCollection 2025.
3
Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy.
工程化癌症纳米疫苗:癌症治疗的新前沿
Nanomicro Lett. 2024 Sep 30;17(1):30. doi: 10.1007/s40820-024-01533-y.
4
Fusogenic vesicular stomatitis virus combined with natural killer T cell immunotherapy controls metastatic breast cancer.融合性水疱性口炎病毒联合自然杀伤 T 细胞免疫疗法控制转移性乳腺癌。
Breast Cancer Res. 2024 May 15;26(1):78. doi: 10.1186/s13058-024-01818-5.
5
Multiple functions of HMGB1 in cancer.HMGB1在癌症中的多种功能。
Front Oncol. 2024 Apr 25;14:1384109. doi: 10.3389/fonc.2024.1384109. eCollection 2024.
6
Dual-Responsive Supramolecular Polymeric Nanomedicine for Self-Cascade Amplified Cancer Immunotherapy.双重响应超分子聚合物纳米医学用于自我级联放大的癌症免疫治疗。
Adv Sci (Weinh). 2024 May;11(20):e2305382. doi: 10.1002/advs.202305382. Epub 2024 Mar 17.
7
Musashi-2 potentiates colorectal cancer immune infiltration by regulating the post-translational modifications of HMGB1 to promote DCs maturation and migration.Musashi-2通过调节高迁移率族蛋白B1(HMGB1)的翻译后修饰来增强结直肠癌的免疫浸润,从而促进树突状细胞(DCs)的成熟和迁移。
Cell Commun Signal. 2024 Feb 12;22(1):117. doi: 10.1186/s12964-024-01495-z.
8
Damage-Associated Molecular Patterns, a Class of Potential Psoriasis Drug Targets.损伤相关分子模式,一类潜在的银屑病药物靶点。
Int J Mol Sci. 2024 Jan 7;25(2):771. doi: 10.3390/ijms25020771.
9
Sterile inflammation in liver transplantation.肝移植中的无菌性炎症。
Front Med (Lausanne). 2023 Aug 10;10:1223224. doi: 10.3389/fmed.2023.1223224. eCollection 2023.
10
A two-decade journey in identifying high mobility group box 1 (HMGB1) and procathepsin L (pCTS-L) as potential therapeutic targets for sepsis.二十年来,人们一直在寻找高迁移率族蛋白 B1(HMGB1)和组织蛋白酶 L(pCTS-L)作为脓毒症潜在治疗靶点。
Expert Opin Ther Targets. 2023 Jul-Dec;27(7):575-591. doi: 10.1080/14728222.2023.2239495. Epub 2023 Jul 25.